Skip to main content

Animations

MJFF Publications

2251 - 2260 of 9034 Results
Title
Year
  • Year
  • 2011
  • 2013
  • 2014
  • 2015
  • 2018
  • 2009
  • 2011
  • 2011
  • 2012
  • 2013
  • Summary Details
    RESTRICTED
    Title: Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?
    Journal Name: Neurosurgery
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1227/neu.0b013e3182160456
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-013-0222-5
    Citation Count: 114
  • Summary Details
    OPEN
    Title: A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-014-0294-x
    Citation Count: 106
  • Summary Details
    RESTRICTED
    Title: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-015-0404-4
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-018-0620-9
    Citation Count: 11
  • Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    2009
    Summary Details
    RESTRICTED
    Title: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-009-9140-z
    Citation Count: 256
  • Summary Details
    OPEN
    Title: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Pathophysiology of manganese-associated neurotoxicity
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2011.12.010
    Citation Count: 133
  • Summary Details
    RESTRICTED
    Title: Increased risk of parkinsonism associated with welding exposure
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2012.08.011
    Citation Count: 161
  • Summary Details
    OPEN
    Title: Screening for early detection of parkinsonism using a self-administered questionnaire: A cross-sectional epidemiologic study
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2013.08.010
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.